Abstract:ObjectiveLynch syndrome is a malignant tumor syndrome with autosomal dominant inheritance. Preliminary screening of patients based on family history of tumor is currently the main method for Lynch syndrome screening. This study aimed to determine the proportion of colorectal cancer patients who met the clinical criteria of Lynch syndrome in China and were finally diagnosed with Lynch syndrome, as well as the opportunities and challenges that next-generation sequencing brought to the clinical diagnosis and treatment of Lynch syndrome. MethodsFrom February 2017 to October 2019, 85 unrelated patients were enrolled in 7 hospitals (The Second Affiliated Hospital, Zhejiang University School of Medicine; Peking Union Medical College Hospital; Jiangsu Province Hospital; Peking University First Hospital; Liaoning Cancer Hospital & Institute; West China Hospital; Wenzhou Central Hospital) with colorectal cancer who met the Chinese clinical criteria for Lynch syndrome, and detected the germline variants using a next-generation sequencing panel containing 61 genes that have been reported to be related to hereditary tumors. For the variants of uncertain clinical significance, the pathogenic significance of the variants is determined by Sanger sequencing and multiplex fluorescent PCR capillary electrophoresis to detect microsatellite status of tumor tissues. ResultsAmong the colorectal cancer patients who met the clinical criteria for Lynch syndrome in China, 28.2% were detected with pathogenic or likely pathogenic germline variants in Lynch syndrome-related genes, and 15.3% of patients carried variants of uncertain clinical significance of these genes. In the analysis of variants of uncertain significance, we suppose that the MLH1 read-through variant (c.2240_2255 delCTGATCTATACAAAGT) is a pathogenic variant of Lynch syndrome. Additionally, there is still insufficient evidence to show that MLH3 gene exon 2-11 duplication is closely related to the occurrence of hereditary colorectal cancer. ConclusionsThis study found that, also based on colorectal cancer patients who met the Chinese clinical criteria of Lynch syndrome, next-generation sequencing did not improve the diagnosis rate of Lynch syndrome compared with previous researches using Sanger sequencing. At the same time, it also brought a large number of variants of uncertain significance. Therefore, we need to be cautious about the results of genetic test. If necessary, in-depth pedigree research and comprehensive molecular testing should be carried out to clarify the clinical significance of these variants.

A pedigree survey of familial ovarian cancer

Increased risk of cancer among relatives of patients with lung cancer in China

The Study of Familial Aggregation of Endometrial Carcinoma

The Clinical Picture and Fecundity of Primary and Recurrent Ovarian Endometriosis with Family History: A Retrospective Analysis

A Genome-Wide Association Study Identifies a New Ovarian Cancer Susceptibility Locus on 9P22.2.

Identification of <i>BRCA1</i>:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

[Clinical-Based Study of Ovarian Cancer Patients with and Without BRCA1/2 Genes Mutation: Clinical Features and Pedigree Analysis].

Genetic spectrum of familial colorectal cancer based on Chinese clinical criteria of Lynch syndrome: study based on a multicenter population

Attention should be paid to hereditary ovarian cancer

The Progress of Colorectal Polyposis Syndrome in Chinese Population.

Correlation between family history and characteristics of breast cancer

Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes.

Identifying Sequence Variants of 18 Hereditary Ovarian Cancer-Associated Genes in Chinese Epithelial Ovarian Cancer Patients.

Comparison of Other Cancers in Chinese Han Women with Familial and Sporadic Breast Cancer

Lung Cancer Risk in Non-Smoking Females with a Familial History of Cancer: a Multi-Center Prospective Cohort Study in China

EP1029 A Preliminary Study of Genetic Susceptibility and Treatment Related Gene Profiling in Chinese Ovarian Cancer Patients

Clinical characteristics and genetic analysis of a case of a patient with familial hereditary breast cancer: a case report

Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.

Susceptibility Genes of Hereditary Ovarian Cancer Syndrome

Analysis of life time risk of different cancer in patients with hereditary nonpolyposis colorectal cancer

Risk of Malignancy Associated with a Maternal Family History of Cancer